Tag: Patent
Canadian Perspectives on Competition Law and Reverse Payments Following FTC v....
David Rosner, Navin Joneja, Joshua Krane, Sep 30, 2013
The Canadian Competition Bureau, pharmaceutical companies operating in Canada, and Canadian lawyers have been following the...
Reverse Payment Settlements: Presumptively Bad or Usually Acceptable?
Kyle Musgrove, Richard Ripley, Jun 27, 2012
In April 2012, the Federal Trade Commission ("FTC") suffered yet another rebuke of what FTC Chair Jon Leibowitz...
Comment on the EC’s Pharmaceutical Dawn Raids
This article is part of a Chronicle. See more from this Chronicle
Susan Creighton, Scott Russell, Feb 14, 2008
The pharmaceutical industry remains under close examination...
Are Article 82 EC and Intellectual Property Interoperable? The State of...
Maurits Dolmans, Paul-John Loewenthal, Robert O'Donoghue, Apr 19, 2007
The objectives of intellectual property rights (IPR) and competition law are essentially the same: both promote...
Illinois Tool Works v. Independent Ink
This article is part of a Chronicle. See more from this Chronicle
Joshua Wright, Jan 25, 2007
The contractual arrangement in Independent Ink is a classic...
